Literature DB >> 2126266

Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.

M Vaneechoutte1, G Verschraegen, G Claeys, B Weise, A M Van den Abeele.   

Abstract

Nonselective media and previously described selective media were used to study the occurrence of Moraxella (Branhamella) catarrhalis in sputum samples of good and poor quality and in samples taken from different sites of the upper respiratory tracts of healthy subjects. It was found that in healthy adults the carrier rate was 5.4%, as opposed to 50.8% in children and 26.5% in people older than 60 years. M. catarrhalis was recovered significantly more often from sputum samples of good quality (5%) than from poor quality samples (0.5%), and when present, it was found mostly in the presence of high inocula. From these data gathered from healthy and diseased subjects, it is concluded that the presence of M. catarrhalis in the sputum of adults is rarely due to oronasopharyngeal contamination of the sputum. Similar findings reported by others are discussed, and the origins of the currently held concept that M. catarrhalis is a common commensal organism of the human upper respiratory tract are traced.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126266      PMCID: PMC268254          DOI: 10.1128/jcm.28.12.2674-2680.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  [Bacteriological diagnosis of species of the genera Neisseria and Branhamella].

Authors:  J Y Riou; M Guibourdenche
Journal:  Ann Biol Clin (Paris)       Date:  1977       Impact factor: 0.459

2.  Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.

Authors:  D J McNeely; C S Kitchens; R M Kluge
Journal:  Am Rev Respir Dis       Date:  1976-08

Review 3.  Are the "nonpathogenic" Neisseriae pathogenic?

Authors:  D A Herbert; J Ruskin
Journal:  Am J Clin Pathol       Date:  1981-05       Impact factor: 2.493

4.  The correlation between bacteriological findings in the nose and maxillary sinus in acute maxillary sinusitis.

Authors:  A Axelsson; J E Brorson
Journal:  Laryngoscope       Date:  1973-12       Impact factor: 3.325

5.  Immune complexes and complement in serous and mucoid otitis media.

Authors:  A B Laurell; N I Nilsson; K Prellner
Journal:  Acta Otolaryngol       Date:  1980 Sep-Oct       Impact factor: 1.494

6.  Rapid identification of Branhamella catarrhalis with 4-methylumbelliferyl butyrate.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; P Flamen
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

7.  Sensitivity of Branhamella catarrhalis to oral antibiotics.

Authors:  I Kallings
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Microbiological studies of the bacterial flora of the external auditory canal in children.

Authors:  I Brook
Journal:  Acta Otolaryngol       Date:  1981 Mar-Apr       Impact factor: 1.494

9.  Selective medium with DNase test agar and a modified toluidine blue O technique for primary isolation of Branhamella catarrhalis in sputum.

Authors:  J L Soto-Hernandez; D Nunley; S Holtsclaw-Berk; S L Berk
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults.

Authors:  J S Knapp; E W Hook
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

View more
  42 in total

1.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

Review 2.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

Review 3.  Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.

Authors:  T F Murphy
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

4.  Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.

Authors:  J J Christensen; N Q Hansen; B Bruun
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  The other siblings: respiratory infections caused by Moraxella catarrhalis and Haemophilus influenzae.

Authors:  Larry Lutwick; Laila Fernandes
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

6.  Moraxella catarrhalis bacteraemia and prosthetic valve endocarditis.

Authors:  Lokesh Shahani; Shahriar Tavakoli Tabasi
Journal:  BMJ Case Rep       Date:  2015-10-23

Review 7.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease.

Authors:  Grant A Mackenzie; Amanda J Leach; Jonathan R Carapetis; Janelle Fisher; Peter S Morris
Journal:  BMC Infect Dis       Date:  2010-10-23       Impact factor: 3.090

9.  Comparison of randomly amplified polymorphic DNA analysis and pulsed-field gel electrophoresis for typing of Moraxella catarrhalis strains.

Authors:  H Vu-Thien; C Dulot; D Moissenet; B Fauroux; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.

Authors:  Taketo Otsuka; Charmaine Kirkham; Aimee Brauer; Mary Koszelak-Rosenblum; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.